E-DRUG: Antiretroviral (ARV) Program Management Issues in Low Resource Settings: A Training Seminar for Policy Makers & Program Managers
--------------------------------------------
Dates: August 8 - August 19, 2005
Hosts: WHO Collaborating Center in Pharmaceutical Policy / Boston
University School of Public Health
Location: Boston University School of Public Health, Boston, MA, USA
**PLEASE NOTE: Student Visas are not required for the conference.**
Course Objectives
Funding through Global Fund, PEPFAR, and other initiatives has recently
transformed AIDS into a treatable disease in developing and transitional
countries. Resources such as ARVs and diagnostics are now available;
however, rapid scale-up of AIDS treatment programs has not occurred, in
part, due to ARV drug management issues. ARV drug management issues include
difficulties with pharmaceutical supply systems and logistics as well as
insufficient attention paid to ARV adherence.
Seminar Overview/Course Content
Week One (August 8-12, 2005): Drug Management Key Issues
A description of the various national and international players involved in
ARV management will be discussed with recommendations to efficiently
coordinate efforts. Specific drug management issues to be covered include:
quantification, procurement, pricing, quality assurance, and
pre-qualification of suppliers.
Week 2 (August 15-19, 2005): ARV Adherence
An overview of adherence issues will be followed by instruction on how to
measure ARV adherence. Approaches to improve adherence to AIDS and other
chronic diseases will be presented. A field visit to an ARV adherence clinic
will allow participants an opportunity to interact with health care
practitioners (pharmacists, physicians, nurses, social workers,
nutritionists) involved in ARV adherence activities.
Who Should Attend?
Policy makers, ARV Program Managers, and NGO Officials responsible for
national and local programs. Social scientists, pharmacists, and other
public health professionals interested in adherence and ARVs
Teaching Methods/Course Design
Instruction will occur in English. The format will be highly interactive
with presentations by international experts followed by facilitated group
exercises and discussion. Case studies and guided readings will be provided
and substantial preparation is required for each session. A field visit to
an ARV Adherence Clinic will be arranged.
Faculty
Brenda Waning, Boston University School of Public Health;
Libby Levison, Pharmaceutical Consultant;
Richard Laing, World Health Organization, Geneva;
Michael Montagne, Mass. College of Pharmacy;
Warren Kaplan, Boston University School of Public Health
Training Costs
Conference costs (no academic credit): $1,225 USD includes tuition and
materials fee. For those who wish to obtain academic credit (2 credits) for
the course, the cost is $1,974 USD.
For more information, contact Sarah Petty at
ih@bu.edu
or by phone (+1) 617-638-5234